Portfolio Lab

Stryker Corp

  • Stock
  • Ticker SYK
  • ISIN US8636671013
  • NYSE

Health care · Medical technology · USA

$310.00 −0.98%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Stryker Corp since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

SYKGlobal equities (VT)

$10,000 grew to $31,046. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −43.8% in 03/2020, measured from the peak in 02/2020. It took 8 months to get back to the old peak.

1-year return
−13.0%
5-year return p.a.
+4.4%
10-year return p.a.
+12.0%
Volatility p.a.
22.2%
Largest decline
−43.8%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue6,4365,8666,0226,0577,1716,0206,5896,520
Gross profit4,1743,7443,8413,8524,6283,8104,4984,248
Operating income5818371,1131,1351,8049361,6591,034
EBITDA9271,1981,5001,5372,2211,3332,0631,431
Net income5466548848598497451,276753
Earnings per share1.411.692.292.222.201.933.301.96
Balance sheet
Total assets42,97146,00646,33147,05747,84446,29147,93047,247
Liabilities22,33725,07625,14025,27225,42423,31223,94223,790
Equity20,63420,93021,19121,78522,42022,97923,98823,457
Cash3,6522,3202,3753,2564,0112,8783,3913,271
Long-term debt12,18814,38314,82914,84514,85914,22414,19214,176
Cash flow
Operating cash flow1,9312501,1111,5402,1435811,2611,461
Capital expenditure-266-123-183-187-268-166-202-237
Free cash flow1,6651279281,3531,8754151,0591,224

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2019 at +35.3%, weakest 2022 at −7.4%. 7 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
30 Oct 2026$1.96
31 Jul 2026$3.30
11 May 2026$1.93
11 Feb 2026$2.20
31 Oct 2025$2.22
1 Aug 2025$2.29
2 May 2025$1.69
12 Feb 2025$1.41
30 Oct 2024$2.16
31 Jul 2024$2.14
1 May 2024$2.05
14 Feb 2024$2.98

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€107bn
Market cap in trading currency
$118bn
Enterprise value
$130bn
P/E
33.0
P/S
4.49
P/B
5.03
EV/Sales
4.94
EV/EBITDA
18.4
Earnings yield
3.0%
FCF yield
3.9%

Results (last four quarters)

Revenue
$26.3bn
Gross profit
$17.2bn
EBITDA
$7.05bn
Net income
$3.62bn
Earnings per share
$9.39
Revenue per share
$69.08
Revenue growth
+7.6%
Earnings growth
−12.3%

Profitability

Gross margin
65.3%
Operating margin
20.7%
Net margin
13.8%
Return on equity
16.0%
Return on assets
7.7%

Balance sheet and cash flow

Cash
$3.27bn
Cash per share
$8.59
Financial debt
$15.2bn
Debt/equity %
65
Current ratio
2.18
Book value per share
$61.62
Operating cash flow
$5.45bn
Free cash flow
$4.57bn

Dividend

Dividend yield
1.14%
Dividend (12 months)
$3.52
Yield (12 months)
1.14%
Payout ratio
37%
Ex-dividend date
30 Sep 2026

Shares and trading

Shares outstanding
381m
Volume
2.38m
Avg. volume 3 months
2.91m
Relative volume
0.8

Price and technicals

Price
$310.00
1 day
−1.0%
52-week high
$387.46
52-week low
$269.75
Distance to 52-week high
−20.0%
Distance to 52-week low
+14.9%
Distance to 50-day line
+4.9%
Distance to 200-day line
−3.3%
RSI (14)
50
Volatility 1M
48.4%

Performance

1 week
+0.1%
1 month
+1.0%
3 months
−5.4%
6 months
−2.0%
YTD
−11.8%
1 year
−14.9%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has SYK performed since 11/2016?

$10,000 grew to $31,046 by 20 Nov 2026, which is +12.0% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is SYK?

Volatility was 22.2% per year, measured on monthly returns. The largest decline from a peak was −43.8%, with the low in 03/2020.

How does SYK compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, SYK returned +12.0% at 22.2%. The correlation of monthly returns was 0.58; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Stryker Corp (SYK): Return and risk | Portfolio Lab